JP4344241B2 - トリアジン誘導体、およびサンスクリーンとしてのその使用 - Google Patents

トリアジン誘導体、およびサンスクリーンとしてのその使用 Download PDF

Info

Publication number
JP4344241B2
JP4344241B2 JP2003521215A JP2003521215A JP4344241B2 JP 4344241 B2 JP4344241 B2 JP 4344241B2 JP 2003521215 A JP2003521215 A JP 2003521215A JP 2003521215 A JP2003521215 A JP 2003521215A JP 4344241 B2 JP4344241 B2 JP 4344241B2
Authority
JP
Japan
Prior art keywords
sub
alkyl
acid
unsubstituted
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003521215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501855A5 (https=
JP2005501855A (ja
Inventor
ワーグナー，バルバラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Holding AG filed Critical Ciba Holding AG
Publication of JP2005501855A publication Critical patent/JP2005501855A/ja
Publication of JP2005501855A5 publication Critical patent/JP2005501855A5/ja
Application granted granted Critical
Publication of JP4344241B2 publication Critical patent/JP4344241B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003521215A 2001-08-17 2002-08-08 トリアジン誘導体、およびサンスクリーンとしてのその使用 Expired - Fee Related JP4344241B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01810796 2001-08-17
CH16992001 2001-09-14
PCT/EP2002/008888 WO2003016289A1 (en) 2001-08-17 2002-08-08 Triazine derivatives and their use as sunscreens

Publications (3)

Publication Number Publication Date
JP2005501855A JP2005501855A (ja) 2005-01-20
JP2005501855A5 JP2005501855A5 (https=) 2006-01-05
JP4344241B2 true JP4344241B2 (ja) 2009-10-14

Family

ID=25739004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521215A Expired - Fee Related JP4344241B2 (ja) 2001-08-17 2002-08-08 トリアジン誘導体、およびサンスクリーンとしてのその使用

Country Status (7)

Country Link
US (1) US7038046B2 (https=)
EP (1) EP1423371B1 (https=)
JP (1) JP4344241B2 (https=)
AT (1) ATE485281T1 (https=)
DE (1) DE60238066D1 (https=)
DK (1) DK1423371T3 (https=)
WO (1) WO2003016289A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7574545B2 (en) * 2000-10-16 2009-08-11 Electronics For Imaging, Inc. Method and apparatus for controlling a document output device with a control request stored at a server
US6748471B1 (en) * 2000-10-16 2004-06-08 Electronics For Imaging, Inc. Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer
FR2867188A1 (fr) * 2004-03-03 2005-09-09 Oreal Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri
US20070286827A1 (en) * 2006-06-12 2007-12-13 Esschem, Inc. Optical brighter and uv stabilizer for acrylic enhancements
WO2008003064A2 (en) * 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
WO2008022946A1 (en) * 2006-08-24 2008-02-28 Unilever Plc Photostable cosmetic compositions
US20080096782A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials
US20080097070A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous polyamine-containing systems for water-insoluble materials
AU2010223919B2 (en) 2009-03-13 2016-03-31 Les Laboratoires Servier Methods and compositions for cell-proliferation-related disorders
RU2561132C2 (ru) 2009-06-29 2015-08-20 Аджиос Фармасьютикалз, Инк. Производные хинолинсульфонамидов и их применение для модулирования пкм2 активности
EP3561077B1 (en) 2009-10-21 2022-12-21 Les Laboratoires Servier Methods for cell-proliferation-related disorders
CA2797158A1 (en) 2010-05-10 2011-11-17 Segetis, Inc. Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof
TWI519569B (zh) * 2010-12-28 2016-02-01 Nissan Chemical Ind Ltd A coating solution for forming a polyimide film, a liquid crystal aligning agent, a polyimide film, a liquid crystal alignment film, and a liquid crystal display element
WO2012092546A2 (en) * 2010-12-30 2012-07-05 L'oreal S.A. Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax
SG194697A1 (en) 2011-05-03 2013-12-30 Agios Pharmaceuticals Inc Pyruvate kinase activators for use in therapy
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
NZ627096A (en) 2012-01-06 2017-02-24 Agios Pharmaceuticals Inc Triazinyl compounds and their methods of use
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
WO2014062511A1 (en) 2012-10-15 2014-04-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
MY185687A (en) 2013-07-11 2021-05-30 Agios Pharmaceuticals Inc N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
CN105593215B (zh) 2013-07-11 2019-01-15 安吉奥斯医药品有限公司 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
KR20240010105A (ko) 2014-03-14 2024-01-23 아지오스 파마슈티컬스 아이엔씨. 치료적으로 활성인 화합물의 약제학적 조성물
FI3307271T3 (fi) 2015-06-11 2023-10-17 Agios Pharmaceuticals Inc Pyruvaattikinaasin aktivaattorien käyttämisen menetelmä
SG11201803088PA (en) 2015-10-15 2018-05-30 Agios Pharmaceuticals Inc Combination therapy for treating malignancies
PT3362066T (pt) 2015-10-15 2021-11-16 Celgene Corp Terapia de combinação para tratar malignidades
CN107827764A (zh) * 2017-11-27 2018-03-23 上海应用技术大学 一种双β‑氨基酮或双β‑氨基酯类的制备方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4105923A1 (de) * 1991-02-26 1992-08-27 Basf Ag P-aminozimtsaeure-substituierte triazine
DE4223890A1 (de) * 1992-02-19 1993-08-26 Merck Patent Gmbh Triazin-derivate
FR2744721B1 (fr) * 1996-02-12 1999-06-18 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations

Also Published As

Publication number Publication date
ATE485281T1 (de) 2010-11-15
DK1423371T3 (da) 2011-02-07
WO2003016289A1 (en) 2003-02-27
DE60238066D1 (de) 2010-12-02
EP1423371B1 (en) 2010-10-20
JP2005501855A (ja) 2005-01-20
EP1423371A1 (en) 2004-06-02
US20040242579A1 (en) 2004-12-02
US7038046B2 (en) 2006-05-02

Similar Documents

Publication Publication Date Title
JP4344241B2 (ja) トリアジン誘導体、およびサンスクリーンとしてのその使用
JP4154719B2 (ja) 化粧品用途のためのメロシアニン誘導体
KR102434710B1 (ko) 화장품 uv 흡수제의 혼합물
CN101711151B (zh) Uv-敏感活性成分的稳定作用
AU2003205656B2 (en) Micropigment mixtures
JP4088254B2 (ja) ヒドロキシフェニルトリアジン化合物を含むｕｖ吸収剤組成物
JP4671953B2 (ja) Ｕｖ吸収剤としてのトリアジン誘導体
US20090068129A1 (en) Aminophenylbenzothiazole compounds
KR20110112443A (ko) 화장품 조성물의 안정화
JP6821555B2 (ja) 化粧用ｕｖ吸収体混合物
JP5559186B2 (ja) ホスホノ基を含有するベンジリデン化合物
JP4230353B2 (ja) ビフェニレン化合物
ES2354870T3 (es) Derivados de triazina y sus usos como protectores solares.
BRPI0406835B1 (pt) Derivados de triazina como absorvedores de uv, processo para sua preparação e preparação cosmética contendo os mesmos
AU2002333740A1 (en) Biphenylene compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050803

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050803

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081028

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090526

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090707

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090710

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120717

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees